An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
DAY 1, FRIDAY, 6th MAY 2016
Pharmacokinetics of low doses
Speaker : Dr. Vikram Gota, Mumbai
Repositioning of drugs in oncology : The ReDo project
Speaker : Dr. Pan Pantziarka, Belgium
Key note lecture : Next - generation drug repositioning : using high-through put screening technology to improve cancer treatment
Speaker : Dr. Eddy Pasquier, France
Randomized phase 2 studies in metronomic therapy
Speaker : Dr. Sudeep Gupta, Mumbai
Randomized phase 3 studies in metronomic therapy
Speaker : Dr. Kumar Prabhash, Mumbai
Radiologist View:
Speaker : Dr. Abhishek Mahajan, Mumbai
Nuclear Medicine view
Speaker : Dr. Nilendu Purandare, Mumbai
Appropriate clinical end point selection for metronomic studies
Speaker : Dr. Atanu Bhattacharjee, Thalassary
Tumor Immunity related marker selection and methodologies for metronomic studies
Speaker : Dr. Shubhada Chiplunkar, Navi Mumbai
Efficacy V/s. Toxicity endpoint selection for metronomic studies
Speaker : Dr. Sadhana K, Navi Mumbai
Mathematical modelling of chemotherapy scheduling
Speaker : Dr. Sebastien Benzekry, France
Systematic analysis of host and tumor effects to metronomic chemotherapy regimen
Speaker : Dr. Yuval Shaked, Israel
For Tumor shrinkage
Speaker : Dr. Amish Vora, Delhi
For Clinical benefit rate
Speaker : Dr. Randeep Singh, Delhi
Panel Discussion : Survey of practice, perception and promise in Metronomic therapy and generation of a consensus statement
Moderator : Dr. Purvish Parikh, Mumbai & Dr. Vanita Noronha, Mumbai